The androgen receptor (AR) is a ligand-dependent transcription factor that plays a crucial role in the development and homeostasis of the prostate and in prostate cancer. The transcriptional activity of AR is mediated by interaction with multiple co-activators, which serve in chromatin modification or remodeling, or provide a link between specific and general transcription factors. We have identified zipper interacting protein (ZIP) kinase as a novel transcriptional co-activator of the AR. ZIP kinase enhanced expression of AR-responsive promotor/ luciferase reporter constructs in a hormone-and kinasedependent manner. Similar results were obtained for glucocorticoid receptor but not for progesterone receptor and estrogen receptor. Following hormone treatment, AR and ZIP kinase formed physical complexes and associated with the promoter and enhancer of the prostate-specific antigen gene, as revealed by chromatin immunoprecipitation. Strikingly, depletion of ZIP kinase by siRNA led to significant reduction of AR-mediated transactivation. The interaction of ZIP kinase with AR seems to be mediated in part by apoptosis antagonizing transcription factor and in part by direct binding. Interestingly, AR was not phosphorylated by ZIP kinase in vitro, suggesting that it phosphorylates other co-activators or chromatin proteins.
Introduction
Nuclear receptors comprise a large family of liganddependent transcription factors that play a role in diverse physiological processes such as growth control, differentiation and apoptosis. One of the best-studied nuclear receptors is the androgen receptor (AR). The AR is in focus of intense research for two reasons: first, it provides a powerful system for studying transcription in the context of chromatin, and second, it plays a key role in the development of prostate cancer (for reviews, see Debes and Tindall 2002; McEwan 2004; Taplin and Balk, 2004) . In the absence of hormone, AR is kept in the cytoplasm by complex formation with chaperones. Upon hormone induction, AR dissociates from the chaperone, translocates to the nucleus and binds as a dimer to response elements in promoter or enhancer regions of its target genes. Subsequently, AR recruits a number of co-activators that actually mediate the transcriptional response. These co-activators function either as adapters, serving in the assembly of transcription initiation complexes, or they are involved in diverse modifications of chromatin proteins, including the receptor itself, or in chromatin remodeling. Thus, histone acetyl transferases, such as SRC-1/p160 and p300/CBP, and methyl transferases, such as CARM-1, were identified as co-activators of nuclear receptors, whereas corepressors exhibit or recruit histone deacetylase activity (for reviews, see Rosenfeld and Glass, 2001; McKenna and O'malley, 2002; Lonard and O'Malley, 2006) .
The list of coregulators is continuously growing. Presently, about 200 coregulators are reported (Lonard and O'Malley, 2006) . We have recently identified apoptosis antagonizing transcription factor (AATF) as a novel co-activator of nuclear receptors (Leister et al., 2003) . AATF, also termed Che-1 (Fanciulli et al., 2000) or Traube (Thomas et al., 2000) , was discovered as an interaction partner of Dlk/ZIPK (DAP-like kinase/ zipper interacting protein kinase) (Page et al., 1999b) , of RNA polymerase II subunit 11 and of the retinoblastoma protein Rb (Fanciulli et al., 2000) . The precise biological function of AATF remains to be elucidated. However, a role as transcriptional activator or coactivator is clearly established. In the case of Rb/E2F and SP1, it was shown that AATF can activate these transcription factors by releasing them from a repressive state by displacement of histone deacetylase1 (Bruno et al., 2002; Di Padova et al., 2003) . We found a different mechanism for the co-activation of AR, which involves ubiquitination. According to our model, AATF recruits TSG101, an inactive ubiquitin conjugase, which in turn stabilizes the AR in a monoubiquitinated, presumably active, state (Burgdorf et al., 2004) . Most recently, AATF/Che1 was shown to be involved in the DNA damage response. Upon DNA damage, AATF/ Che1 is phosphorylated by ataxia telangiectasia mutated (ATM) and checkpoint kinase Chk-2 and upregulates p53 (Bruno et al., 2006) . Whether in this case AATF/Che1 functions as a bona fide transcription factor or as coactivator is not clear. Anyhow, there seem to be different modes by which AATF/Che-1 cooperates with other transcription factors.
Since AATF was originally discovered as an interaction partner of ZIPK (previously termed Dlk), we asked whether ZIPK participates in the co-activation function of AATF. ZIPK is a serine/threonine-specific protein kinase that belongs to the subfamily of DAP kinases (death-associated protein kinases). ZIPK is involved in the regulation of apoptosis, cell motility and contractility, and mitosis, particularly cytokinesis. In these contexts, ZIPK seems to function primarily as a myosin light chain kinase or, during mitosis, as a histone kinase (for reviews and references, see Ko¨gel et al., 2001; Haystead, 2005; Scheidtmann, 2007) . A role of ZIPK in transcription is supported from its interactions with transcription and splicing factors ATF4, AATF and CDC5 (Kawai et al., 1998; Page et al., 1999a, b; Engemann et al., 2002) , and its colocalization with PML bodies (Ko¨gel et al. 1999; Kawai et al., 2003) . Recently, ZIPK was shown to interact with STAT3 and to enhance STAT3-mediated transcription in an interleukin-6-dependent manner (Sato et al., 2005) .
In the following paper, we investigated a functional relationship between AR, AATF and ZIPK. We found that ZIPK enhanced AR-mediated transactivation in a hormone-and kinase-dependent manner. Upon hormone induction, ZIPK interacted with the AR and this interaction was enhanced by AATF. Moreover, both ZIPK and AATF bound to the endogenous prostatespecific antigen (PSA) enhancer, suggesting that they cooperate in the AR-mediated initiation process. Knockdown of ZIPK by siRNA led to significant reduction of AR-dependent transcription. Thus, ZIPK seems to be a novel co-activator of AR.
Results

ZIPK cooperates with AATF in AR-mediated transcription
To investigate whether ZIPK might participate in AR-mediated transcription, we performed transient transactivation assays with a luciferase reporter construct driven by the MMTV (mouse mammary tumor virus) promoter, which is activated by AR and glucocorticoid receptor (GR) (Otten et al., 1988) . Rat1 cells were co-transfected with reporter plasmid together with AR expression construct and increasing amounts of ZIPK expression plasmid. Cells were treated with dihydrotestosterone (DHT) and promoter activation was measured as luciferase activity, as outlined in Materials and methods. As shown in Figure 1a , upper panel, ZIPK enhanced luciferase expression up to fourfold, in an AR-, hormone-, and dose-dependent manner. Moreover, this enhancement by ZIPK required its kinase activity, since it was not observed with the kinase-negative mutant K42A (second last column). Similar results were obtained with two other AR-responsive reporter constructs, one driven by the PSA promoter ( Figure 1a , middle panel) and the other by the p21 CIP1 promoter (lower panel). Moreover, identical results were obtained with other cell lines such as PC3, MCF7 and HEK293 cells. Interestingly, the p21 promoter construct responded even in the absence of hormone, though to lower extent, indicating that this promoter is not strictly AR-dependent. AR-independent activation may be due to endogenous p53.
Next, we investigated whether AATF and ZIPK cooperate in this system. Coexpression of AR and AATF led to twofold enhancement of MMTV-luc transcription, compared to AR alone (Figure 1b, upper panel) . Likewise, coexpression of ZIPK enhanced to a similar extent. Coexpression of AR with both AATF and ZIPK had an additive effect. Similar results were obtained with the other reporter constructs (data not shown). To see whether the cooperative effect of AATF and ZIPK was due to direct interaction of the two proteins, we employed mutants of AATF or ZIPK that are impaired in interaction with the other partners. Thus, AATF or ZIPK mutants lacking their leucine zipper (DLZ) do not interact with wild-type ZIPK or AATF, respectively, and AATF mutant lacking all three LXXLL motifs (mutant DLx) does not interact with AR (Leister et al., 2003) . As shown in Figure 1b , lower panel, all mutants revealed a reduction in co-activation compared to their wild-type counterparts. Equal expression of ectopic proteins was verified by western blotting (data not shown).
Since AATF was also shown to act as co-activator of the estrogen receptor (ER) and GR (Leister et al., 2003) , we asked whether these receptors might also be influenced by ZIPK. Additionally, we included the progesterone receptor (PR). Interestingly, only the GR but not PR or ER was co-activated by ZIPK (Supplementary Figure) . In contrast, the activities of both the GR and ER were enhanced by AATF (see Leister et al., 2003) .
To see whether ZIPK might have a general effect on transcription, we employed two other reporter constructs driven by the SV40 (SV40-luc) or cytomegalovirus early promoters (CMV-luc). In these cases, no enhancement by ZIPK was observed (Figure 1c ). In summary, these experiments revealed an enhancing effect of ZIPK on AR-mediated transactivation. This effect requires the kinase activity of ZIPK and is supported by AATF.
AR and ZIPK form a physical complex in a hormone-dependent manner To investigate whether AR and ZIPK might interact directly, green fluorescent protein-tagged ZIPK and Flag-tagged AR were coexpressed and analysed by immunoprecipitation and western blotting. As shown in Figure 2a , ZIPK was co-precipitated with AR in the presence of hormone but not in its absence. This interaction was even stronger with the kinase-negative mutant of ZIPK, again depending on hormone, indicating that the interaction does not require kinase activity. Identical results were obtained when the tags were reversed (Figure 2b ).
To verify this interaction for endogenous proteins, LNCaP cells with a relatively high level of endogenous AR were subjected to immunoprecipitation with anti-ZIPK and western blotting with anti-AR antibodies. As shown in Figure 2d , AR was indeed co-precipitated with ZIPK in a DHT-dependent manner. However, some AR-ZIPK complexes were precipitated even in the absence of hormone.
We next investigated the time course of association of AR and ZIPK. Samples were taken between 0 and 90 min upon hormone induction. As shown in Figure 2c , the association became prominent after 30 min and remained relatively constant for more than 60 min. Hormone treatment had no effect on the expression level of ZIPK (Figure 2c , lower panel, western blot of lysate).
Mapping the interaction domain for AR in ZIPK
To determine the interaction domain for AR, a set of deletion mutants of ZIPK was employed, as shown in Figure 3a . These mutants lacked either the N-terminal catalytic domain (residues 1-277, termed DN1) or different parts of the C-terminal extra-catalytic domain (termed DC1, DC2, DC3, D276-333 or D276-333DLZ). The mutants were expressed at similar levels as demonstrated in Figure 3b , lysate. Coexpression of ZIPK mutants with Flag-AR and immunoprecipitation with anti-Flag revealed that mutants lacking the leucine zipper (DC1) or further sequences up to residue 337 (DC2-NLS), or the catalytic domain (DN1), were still capable of interacting with AR, whereas mutant DC3-NLS, lacking the entire extra-catalytic domain, was not. This places the interaction domain for AR to the region between residues 275 and 337. To confirm this conclusion, a mutant lacking residues 276-333 was generated. Surprisingly, this mutant exhibited interaction with AR ( Figure 3b , right panel). In contrast, a mutant that additionally lacked the leucine zipper (DC1D276-333) did not. Thus, ZIPK seems to interact with two independent domains, the region between 275 and 333 and the C-terminal leucine zipper. Alternatively, the leucine zipper may interact indirectly via AATF, whereas the upstream region may bind directly (see Discussion).
The AR is not phosphorylated by ZIPK in vitro Since co-activation of the AR required the kinase activity of ZIPK, we asked whether AR might be a substrate of ZIPK. In fact, the AR has four potential phosphorylation Influence of ZIPK and apoptosis antagonizing transcription factor (AATF) on AR-mediated transactivation. HEK293 cells were co-transfected with MMTV-luc, AR, and AATF or ZIPK expression constructs, either alone or in combination; AATF was employed as wild type or mutants DLZ or DLx, as indicated; reporter gene expression was determined as before. (c) ZIPK has no effect on SV40 or the cytomegalovirus (CMV) early promoters. Luciferase reporter constructs driven by the CMV immediate early or the SV40 early promoters were co-transfected with increasing amounts of Flag-ZIPK expression plasmid and luciferase activity was determined as before. All experiments were repeated at least twice and performed in triplicate. For normalization, the plasmid pCMV Renilla encoding Renilla luciferase was included.
sites for ZIPK. Flag-AR was isolated from transfected cells by immunoprecipitation and subjected to in vitro phosphorylation by ZIPK purified from the baculovirus expression system. As a positive control, we employed recombinant Cdk1/Cyclin B, which was shown to phosphorylate AR (Chen et al., 2006) . As control substrate we included histones in the assay. As shown in Figure 4 , the AR was efficiently phosphorylated by Cdk1 but not by ZIPK. That ZIPK was active can be seen from its autophosphorylation and from phosphorylation of histones, particularly H3 and H4 (Figure 4b ). The negative control without exogenous kinase revealed phosphorylation of only histones and other proteins but not of AR. Thus, the AR is not a substrate of ZIPK, at least not in vitro.
Binding of ZIPK and AATF to AR is cooperative We next asked whether the interaction of AR and ZIPK might be mediated or influenced by AATF. To this end, complex formation of endogenous AR and ZIPK was investigated in the absence or presence of ectopically expressed AATF either wild type or mutants DLZ or DLx, which are defective for binding of ZIPK or AR, respectively (see Leister et al., 2003; Figure 1b) . As shown in Figure 5a , expression of wild-type AATF enhanced binding of AR to ZIPK. This effect was reduced with mutant AATF DLZ lacking the interaction domain for ZIPK and eliminated with mutant DLx lacking the interaction motifs for both AR and ZIPK. To see whether the residual binding of ZIPK to AR seen in samples without AATF or with DLx might be mediated by endogenous AATF, we performed a similar experiment upon knocking down AATF expression by siRNA. The results are shown in Figure 5b . AATF-specific siRNA reduced AATF protein levels down to 20% but had no effect on expression of AR or ZIPK. In contrast, control siRNA targeting connexin 43 (Cx43) reduced Cx43 expression but had no effect on AATF or AR or ZIPK. Interestingly, downregulation of AATF reduced but did not eliminate complex formation between AR and ZIPK. Thus, the interaction of AR and ZIPK does not depend on, but seems to be enhanced or stabilized by, AATF. These results correlate with the transactivation data shown in Figure 1b . ZIP kinase is involved in AR-mediated transcription P Leister et al Endogenous ZIPK contributes to AR-mediated transcription If ZIPK contributes to AR-induced transcription, then knockdown of endogenous ZIPK should reduce transcription of AR response genes. Knockdown by siRNA reduced protein levels of ZIPK in HEK293 or LNCaP cells by 90 or 70%, respectively (Figure 6a ). Concomitantly, transactivation of the reporter construct was reduced by 60-70% (Figure 6b ). Control siRNA with a random sequence had no effect. Moreover, ZIPK siRNA had no effect on the level of endogenous AR. This result indicates that AR-mediated transcription does not depend on but is supported by ZIPK, as is typical for co-activators.
ZIPK associates with AR-responsive promoters/enhancers
To investigate whether ZIPK and AATF associate with AR at responsive elements of target genes, we performed chromatin immunoprecipitation (ChIP) analyses and assayed for association with the PSA enhancer, a wellcharacterized AR-responsive structure (Kim and Coetzee, 2004) . At different times after hormone induction, occupation of the PSA enhancer was investigated by ChIP using antibodies specific for ZIPK, AR or AATF. PCR of precipitated chromatin was specific for the PSA enhancer. As shown in Figure 6a , all proteins were present at the PSA enhancer by 45 min and remained bound over the time period examined. It should be noticed that some complex formation was also observed in the absence of hormone. To distinguish whether AR forms a ternary complex with both AATF and ZIPK or rather alternative complexes with either AATF or ZIPK, we performed a re-ChIP experiment. Chromatin was first immunoprecipitated with anti-ZIPK, released and then reprecipitated with anti-AATF or anti-AR (Figure 6b) . Together with the finding that complex formation between AR and ZIPK is enhanced by AATF, this experiment suggests that both ZIPK and AATF associate simultaneously with the AR at AR-responsive promoter/ enhancer elements. However, the existence of binary complexes cannot be ruled out (Figure 7) .
Discussion
This investigation revealed ZIPK as a novel co-activator of the AR. ZIPK enhanced transcription from AR-responsive promoters in a hormone-and kinasedependent manner. Moreover, AR and ZIPK formed a physical complex as shown for ectopically expressed as well as endogenous proteins. This complex formation was again hormone-dependent and appeared to be The androgen receptor (AR) is not phosphorylated by zipper interacting protein kinase (ZIPK) in vitro. Flag-AR was isolated from transfected HEK293 cells and subjected to in vitro phosphorylation with exogenous Cdk1/Cyclin B (positive control) or ZIPK or without kinase (control). The reaction was performed in kinase buffer containing 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, 5 mM MnCl 2 , 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 2 mCi [g À32 P]ATP and 0.3 mg histones at 37 1C for 30 min. The western blot demonstrates that identical amounts of Flag-AR were employed. Panels (a) and (b) show identical samples that were resolved on an 8.5 or 13.5% polyacrylamide gel, respectively, to achieve a higher resolution (a) or to include the phosphorylated histones (b). Autoradiography on Agfa Cronex 5 X-ray film was for 2 h.
ZIP kinase is involved in AR-mediated transcription P Leister et al stabilized by AATF. Significantly, AR, ZIPK and AATF associated with endogenous AR-responsive elements such as the PSA enhancer, as revealed by ChIP analyses. Finally, knockdown of ZIPK by siRNA led to strong reduction of AR-mediated transcription, suggesting that ZIPK is crucial for this process. A role of ZIPK in transcription was suggested from its initial discovery as an interaction partner of ATF4 (Kawai et al., 1998) . However, experimental evidence for this assumption was lacking. In fact, we did not observe any effect of ZIPK on an ATF4-responsive GADD153 promoter-reporter system (H Engemann and KH Scheidtmann, unpublished results). Recently, ZIPK was shown to interact with and enhance the activity of STAT3 in an interleukin-6-dependent manner (Sato et al., 2005) . Thus, co-activation of AR is the second example demonstrating a regulatory role of ZIPK in transcription.
The interaction between AR and ZIPK increased rapidly within the first 30 min after hormone treatment and lasted for at least 90 min when a slight decline was visible. Likewise, the association of ZIPK with the PSA enhancer was detectable for at least 90 min. In contrast, binding of AR to the PSA enhancer appeared to be more stable. This latter finding is in agreement with a recent study showing that assembly of AR and some of its co-activators at responsive promoters/enhancers is a analysis with the indicated antibodies and the precipitated DNA was assayed for the presence of the PSA enhancer by semiquantitative PCR, as described. The PCR products of 366 bp are shown. In (b), chromatin precipitated with anti-ZIPK was eluted and subjected to a second round of ChIP with anti-AATF or anti-AR; input: PCR products from crosslinked chromatin prior to precipitation; sup: supernatant after elution from first antibody; IgG: negative control with unspecific immunoglobulins. Note that some complex formation was observed in the absence of hormone.
ZIP kinase is involved in AR-mediated transcription P Leister et al relatively slow and continuous process (Wang et al., 2005) . Interestingly, the ER behaves quite differently in that the assembly of transcription initiation complexes upon hormone induction is fast but occurs in cycles of about 60 min with alternating binding and clearance (Shang et al., 2000) . The significance of these principally different mechanisms is not clear.
Complex formation between AR and ZIPK seems to be enhanced or stabilized by AATF, suggesting that all three proteins cooperate in a functional complex. This cooperativity was also reflected by the transactivation assays. AATF was originally identified as an interaction partner of ZIPK and later on as a co-activator of steroid hormone receptors. Thus, it was conceivable that ZIPK is recruited to the AR by AATF. Our data suggest that both AATF and ZIPK bind independently but cooperatively to the AR, as binding of ZIPK to AR was enhanced in the presence of wild-type AATF but impaired in the presence of AATF mutants defective for binding ZIPK or AR. Importantly, the interaction between AR and ZIPK was still detectable when AATF was knocked down by siRNA. These data agree well with the data on mapping the interaction domains. The regions mediating the interaction of ZIPK with AR were assigned to two discontinuous regions in ZIPK: the region immediately downstream of the catalytic domain (between residues 275 and 337) and the C-terminal leucine zipper (residues 417-448). However, since the leucine zipper of ZIPK interacts with AATF also, it is indeed possible that AATF facilitates or mediates the initial contact between ZIPK and AR, which subsequently results in direct interaction via the upstream motif. Unfortunately, attempts to distinguish these possibilities by glutathione S-transferase-pull-down binding experiments failed. Perhaps, in vitro-synthesized AR must undergo chaperone-dependent maturation.
Since AATF was shown to co-activate the GR and ER as well, we also included these receptors and the PR in our study. Interestingly, ZIPK enhanced transactivation by GR but not that by ER or PR (Supplementary Figure) , indicating some selectivity.
The question remains how ZIPK exerts its enhancing effect. Since the kinase activity is essential, phosphorylation must be involved. In the case of STAT3, ZIP kinase seems to phosphorylate STAT3 directly (Sato et al., 2005) . The AR is subject to multiple phosphorylations by different kinases such as PKA, PKC, MAP kinases, Akt kinase, and so on (for review, see Gioeli et al., 2002) and Cdk1/Cyclin B (Chen et al., 2006) . However, although the AR has four potential phosphorylation sites for ZIPK, we did not observe a direct phosphorylation in vitro under conditions that revealed efficient phosphorylation by Cdk1/Cyclin B. Thus, alternative targets must be considered. Possible candidates are either other co-activators, particularly steroid receptor coactivators or chromatin proteins, such as histones. Steroid receptor coactivator 1 and steroid receptor coactivator 3 have multiple phosphorylation sites that are targeted by different signaling pathways. Interestingly, a certain combination of phosphorylations seems to determine promoter specificity, perhaps by regulating interactions with other transcription factors or co-activators (reviewed by Wu et al., 2005) . Future studies will show whether any of these are targeted by ZIPK.
Our findings are significant from several aspects. First, they may provide new insights into AR-mediated transcription. Second, expression of ZIPK in steroid hormone-dependent tumor cell lines is relatively high. Thus, ZIPK might contribute to anti-apoptotic and proliferative functions of AR and provide a growth advantage to cancer cells. Third, two other interaction partners of ZIPK, namely Par-4 (Page et al., 1999a) and STAT3 (Sato et al., 2005) , are also linked to the AR (Ueda et al., 2002; Gao et al., 2006) . It will be interesting to elucidate a possible network in which ZIPK cooperates with different co-activators to activate distinct sets of AR target genes.
Materials and methods
Mammalian cell culture and transfection Rat1 and HEK293 cells were maintained in Dulbecco's minimal essential medium (Sigma, Taufkirchen, Germany) supplemented with 5 or 10% fetal bovine serum respectively (Biochrom Seromed, Berlin, Germany). MCF7 cells (human breast carcinoma), LNCaP and PC3 cells (human prostate carcinoma) were grown in RPMI medium containing 10% fetal calf serum. Transfections were carried out either by calcium phosphate co-precipitation, as for Rat1 and HEK293, or by lipofection with jetPEI (QBiogene, Heidelberg, Germany) as for MCF-7 and PC3 cells.
Transactivation assays
Transactivation assays were performed essentially as described (Lohrum and Scheidtmann, 1996; Leister et al., 2003) . Briefly, cells were transfected with the indicated amounts of reporter and expression plasmids while keeping the total amounts of transfected DNA constant. Upon treatment with 10 nM DHT, cells were washed with phosphate-buffered saline (PBS) and lysed in 100 mM KHPO 4 , pH 7.8, 0.2% Triton X-100 and 1 mM dithiothreitol (DTT). Luciferase activity was determined in a reaction mixture containing 20 mM tricine, 1 mM MgCO 3 , 2.6 mM MgSO 4 , 0.1 mM EDTA, 33.3 mM DTT, 270 mM coenzyme A, 470 mM D-luciferin and 530 mM ATP, and measured in an Orion Microplate Luminometer (Berthold, Bad Wildbad, Germany). All transactivation experiments were performed in triplicate and repeated at least twice. For normalization, the plasmid pCMV Renilla encoding Renilla luciferase was included.
Plasmids
The origin and construction of expression plasmids coding for AR, GR, PR, ER, AATF and ZIPK and respective mutants thereof have been described (Page et al., 1999a, b; Muller et al., 2000; Leister et al., 2003; Burgdorf et al., 2004; Felten et al., 2007) . Mutants of ZIPK with deletion of residues 275-333 were constructed by fusion of N-and C-terminal parts of ZIPK, which were generated by PCR using terminal primers (Ko¨gel et al., 1999) and the following internal primers: 333-fw. 5 0 -ccggaattcgctgcgcgagctgcagcggg-3 0 and 275-rev. 5 0 -ggaattcga atgctccaggctctgtgcgatgg-3 0 , containing EcoRI restriction sites for fusion. Reporter plasmids included MMTV-luc (Leister et al., 2003) , p21-luc (Lohrum and Scheidtmann, 1996) , PSA-enhancer-luc (kindly provided by R Schuele, Freiburg, Germany) and PSA-promoter-luc. The latter was constructed by amplifying the region encompassing the PSA-promoter from HeLa genomic DNA by PCR and cloning into pGL3-luc vector using the following primers: fw. 5 0 -cggtaccacattgtttgct gcacg-3 0 ; rev. 5 0 -gctaggctctccgggtgcaggtg-3 0 . All cloning experiments were performed using standard methods.
Immunoprecipitation
Immunoprecipitations of endogenous or tagged proteins were carried out as described previously (Page et al., 1999a) with some modifications. Briefly, cells were washed with PBS, lysed in phosphate lysis buffer (see above) for 15 min on ice, treated with benzonase (Novagen/Merck, Nottingham, UK) for 10 min and the resulting extract was cleared by centrifugation at 13 000 g for 10 min at 4 1C. The supernatant was subjected to immunoprecipitation by anti-GFP (Clontech), anti-Flag (Sigma), anti-ZIPK (Calbiochem/Merck, Nottingham, UK), anti-AR (Santa Cruz, Heidelberg, Germany) or anti-AATF/ Che-1 (kindly provided by M Fanciulli, Rome, Italy) and protein-G agarose. Immunoprecipitated proteins were visualized by western blotting with respective antibodies according to standard procedures.
Chromatin immunoprecipitation
Chromatin immunoprecipitation was carried out as described (Nelson et al., 2006) with some modifications. Cells were kept in RPMI medium without phenol red containing 10% charcoal-stripped fetal calf serum (PAN-Biotech, Aidenbach, Germany) and treated with 10 nM DHT as indicated. Cells were washed with PBS and fixed with 1% paraformaldehyde in PBS at room temperature for 10 min. Cells were washed twice with ice-cold PBS and resuspended in 1 ml IP buffer (150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.5% NP40, 50 mM Tris-HCl pH 7.5, 0.5 mM DTT and 1 Â complete protease inhibitor mix (Roche Diagnostics, Mannheim, Germany)). Nuclei were pelleted by centrifugation at 800 g at 4 1C for 3 min and resuspended in 300 ml of IP buffer. Chromatin was sonicated with a Branson sonicator (Branson, New Brunswick, NJ, USA) with a microtip, 40% output, for 8 Â 10 s, to obtain an average size of 1 kb. Insoluble material was removed by centrifugation at 13 000g at 4 1C for 10 min. A 150 mg portion of fragmented chromatin was diluted in 1 ml IP buffer and incubated overnight with 0.5-1 mg of respective antibodies followed by adsorption to protein-A-sepharose for 1 h. The immunoprecipitates were washed sequentially in TSEI (1% Triton X-100, 0.1% SDS, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-HCl, pH 8.0), TSEII (1% Triton X-100, 0.1% SDS, 2 mM EDTA, 500 mM NaCl, 20 mM Tris-HCl, pH 8.0) and buffer III (250 mM LiCl, 1% NP40, 1% Deoxycholate, 1 mM EDTA, 10 mM Tris-HCl, pH 8.0) followed by three washes in TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA), each step for 10 min at 4 1C. DNA fragments were eluted with 10% Chelex-100 suspension (Bio-Rad, Munich, Germany) in TE and boiled for 12 min, to revert crosslinking. For ReChIP analyses, the precipitated complexes were eluted from antibodies in 10 mM DTT at 37 1C for 30 min under shaking. The supernatant was diluted 1:50 in dilution buffer (1% Triton X-100, 150 mM NaCl, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0) and subjected to another round of immunoprecipitation, as described above. Relative amounts of precipitated PSA promotor/enhancer DNA fragments were determined by semiquantitative PCR, using GoTaq polymerase (Promega, Mannheim, Germany).
RNAi experiments
LNCaP or HEK293 cells were grown on coverslips in phenol redfree medium containing 10% charcoal-stripped fetal calf serum (PAN-Biotech). Cells were co-transfected using DharmaFECT 2 with 100 pM of Dharmacon siRNA against human ZIPK (DAPK3) or control (random) siRNA, and with 200 ng MMTV-luc; HEK293 cells were additionally transfected with 80 ng Flag-AR expression plasmid. At 24 h after transfection, cells were provided with 10 nM DHT for another 24 h. Cells were washed with PBS at room temperature, collected and lysed in buffer containing 100 mM KHPO 4 , 0.2% Triton X-100, pH 7.8 and 1 mM DTT and then subjected to luciferase assays and western blot analysis. To reveal the role of AATF in complex formation between ZIPK and AR, AATF was downregulated in HEK293 cells by siRNA of the sequence 5 0 -tggcttgcaatccagaagt tacg-3 0 corresponding to nucleotides 1472-1492 (Maurizio Fanciulli, personal communication).
